Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol-Fentanyl versus Propofol-Lidocaine for hemodynamic stability during upper endoscopy
IRCT20101220005426N11Phase 3Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- Sep 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in None comparing Propofol + Midazolam + Fentanyl with Propofol + Midazolam + Lidocaine (2 arms). Primary endpoints: Reduction of blood pressure fluctuations during upper endoscopy, Reduction of heart rate fluctuations during upper endoscopy and 4 more. Started Sep 2021; status: completed.
02
Drugs
propofolfentanyllidocainemidazolam
Beyond the preview
Go deeper on IRCT20101220005426N11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20101220005426N11.